AU732079B2 - Novel vitamin D receptor related polypeptides, nucleic acid sequence encoding the same and uses thereof - Google Patents

Novel vitamin D receptor related polypeptides, nucleic acid sequence encoding the same and uses thereof Download PDF

Info

Publication number
AU732079B2
AU732079B2 AU90131/98A AU9013198A AU732079B2 AU 732079 B2 AU732079 B2 AU 732079B2 AU 90131/98 A AU90131/98 A AU 90131/98A AU 9013198 A AU9013198 A AU 9013198A AU 732079 B2 AU732079 B2 AU 732079B2
Authority
AU
Australia
Prior art keywords
nucleic acid
seq
leu
polypeptide
vdrry
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU90131/98A
Other languages
English (en)
Other versions
AU9013198A (en
Inventor
Anders Berkenstam
Mats Dahlberg
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Swedish Orphan Biovitrum AB
Original Assignee
Pharmacia AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from SE9703745A external-priority patent/SE9703745D0/xx
Application filed by Pharmacia AB filed Critical Pharmacia AB
Publication of AU9013198A publication Critical patent/AU9013198A/en
Assigned to PHARMACIA AB reassignment PHARMACIA AB Amend patent request/document other than specification (104) Assignors: PHARMACIA & UPJOHN AB
Application granted granted Critical
Publication of AU732079B2 publication Critical patent/AU732079B2/en
Assigned to BIOVITRUM AB reassignment BIOVITRUM AB Alteration of Name(s) in Register under S187 Assignors: PHARMACIA AB
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/72—Receptors; Cell surface antigens; Cell surface determinants for hormones
    • C07K14/721—Steroid/thyroid hormone superfamily, e.g. GR, EcR, androgen receptor, oestrogen receptor
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/18—Drugs for disorders of the endocrine system of the parathyroid hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Rheumatology (AREA)
  • Endocrinology (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Pain & Pain Management (AREA)
  • Emergency Medicine (AREA)
  • Child & Adolescent Psychology (AREA)
  • Nutrition Science (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AU90131/98A 1997-10-14 1998-08-31 Novel vitamin D receptor related polypeptides, nucleic acid sequence encoding the same and uses thereof Ceased AU732079B2 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
SE9703745A SE9703745D0 (sv) 1997-10-14 1997-10-14 New receptors
SE9703745 1997-10-14
SE9801148 1998-03-31
SE9801148A SE9801148D0 (sv) 1997-10-14 1998-03-31 New receptors
PCT/SE1998/001548 WO1999019354A1 (en) 1997-10-14 1998-08-31 Novel vitamin d receptor related polypeptides, nucleic acid sequence encoding the same and uses thereof

Publications (2)

Publication Number Publication Date
AU9013198A AU9013198A (en) 1999-05-03
AU732079B2 true AU732079B2 (en) 2001-04-12

Family

ID=26663102

Family Applications (1)

Application Number Title Priority Date Filing Date
AU90131/98A Ceased AU732079B2 (en) 1997-10-14 1998-08-31 Novel vitamin D receptor related polypeptides, nucleic acid sequence encoding the same and uses thereof

Country Status (9)

Country Link
EP (1) EP1023323A1 (enrdf_load_stackoverflow)
JP (1) JP2001519441A (enrdf_load_stackoverflow)
KR (1) KR20010031120A (enrdf_load_stackoverflow)
CN (1) CN1134452C (enrdf_load_stackoverflow)
AU (1) AU732079B2 (enrdf_load_stackoverflow)
CA (1) CA2306453A1 (enrdf_load_stackoverflow)
NZ (1) NZ504025A (enrdf_load_stackoverflow)
SE (1) SE9801148D0 (enrdf_load_stackoverflow)
WO (1) WO1999019354A1 (enrdf_load_stackoverflow)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2003200641B2 (en) * 1998-01-09 2008-04-03 The Salk Institute For Biological Studies Novel Steroid-activated Nuclear Receptors and Uses therefor

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1044216A4 (en) * 1997-12-12 2001-10-31 Merck & Co Inc DNA MOLECULES ENCODING HUMAN NUCLEAR RECEPTOR PROTEINS, nNR7 AND nNR7-1
US6984773B1 (en) 1998-01-09 2006-01-10 The Salk Institute For Biological Studies Transgenic mice expressing a human SXR receptor polypeptide
US6756491B2 (en) * 1998-01-09 2004-06-29 The Salk Institute For Biological Studies Steroid-activated nuclear receptors and uses therefor
US6911537B2 (en) * 1998-01-09 2005-06-28 The Salk Institute For Biological Studies Xenobiotic compound modulated expression systems and uses therefor
EP1066320A4 (en) * 1998-03-27 2005-03-16 Glaxo Group Ltd ORPHAN NUCLEAR RECEPTOR
US7238491B1 (en) 1998-03-27 2007-07-03 Smithkline Beecham Corporation Pregnane X receptor method
FR2801311B1 (fr) * 1999-11-22 2005-08-26 Centre Nat Rech Scient Polypeptides derives du recepteur nucleaire de la vitamine d, et leurs utilisations notamment dans le cadre du criblage d'analogues de la vitamine d
AU2006200258B2 (en) * 1999-12-09 2009-04-09 The Salk Institute For Biological Studies Novel steroid-activated nuclear receptors and uses therefor
US6514941B1 (en) 1999-12-10 2003-02-04 Campina Melkunie B.V. Method of preparing a casein hydrolysate enriched in anti-hypertensive peptides
US20040053866A1 (en) * 2002-08-21 2004-03-18 The Regents Of The University Of California Tumor suppressor genes and their uses
SE0400489D0 (sv) * 2004-02-27 2004-02-27 Biovitrum Ab Therapeutic proteins

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996022390A1 (en) * 1995-01-17 1996-07-25 The Salk Institute For Biological Studies Methods, polypeptides, nucleotide sequence of xor-6, a vitamin d-like receptor from xenopus

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH03504438A (ja) * 1988-03-30 1991-10-03 アーチ　デベロプメント　コーポレイション アンドロジェンレセプターを含むｄｎａ結合蛋白質
ATE215601T1 (de) * 1991-09-17 2002-04-15 Salk Inst For Biological Studi Rezeptoren der steroid/thyroid superfamilie von rezeptoren
US5756448A (en) * 1992-02-26 1998-05-26 The General Hospital Corporation Constitute activator of retinoid (CAR) receptor polypeptides
AU5426596A (en) * 1995-05-16 1996-11-29 Salk Institute For Biological Studies, The Modulators for new members of the steroid/thyroid superfamily of receptors

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996022390A1 (en) * 1995-01-17 1996-07-25 The Salk Institute For Biological Studies Methods, polypeptides, nucleotide sequence of xor-6, a vitamin d-like receptor from xenopus

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2003200641B2 (en) * 1998-01-09 2008-04-03 The Salk Institute For Biological Studies Novel Steroid-activated Nuclear Receptors and Uses therefor

Also Published As

Publication number Publication date
WO1999019354A9 (en) 1999-12-02
JP2001519441A (ja) 2001-10-23
EP1023323A1 (en) 2000-08-02
CA2306453A1 (en) 1999-04-22
WO1999019354A1 (en) 1999-04-22
SE9801148D0 (sv) 1998-03-31
NZ504025A (en) 2003-04-29
CN1134452C (zh) 2004-01-14
AU9013198A (en) 1999-05-03
KR20010031120A (ko) 2001-04-16
CN1279689A (zh) 2001-01-10

Similar Documents

Publication Publication Date Title
AU732079B2 (en) Novel vitamin D receptor related polypeptides, nucleic acid sequence encoding the same and uses thereof
JP2002300893A (ja) ヒト成長ホルモン
JP2003527067A (ja) Ａｃｒｐ３０（３０ｋｄの脂肪細胞補体関連タンパク質）の相同体ａｃｒｐ３０ｒ１ｌ
JP2002512781A (ja) Ｇタンパク質共役型７ｔｍ受容体（ａｘｏｒ−１）
AU721194B2 (en) Thrombin receptor homolog
Mizutani et al. Cloning and characterization of gonadotropin-inducible ovarian transcription factors (GIOT1 and-2) that are novel members of the (Cys) 2-(His) 2-type zinc finger protein family
US20090142351A1 (en) Human and rat PGC-3, PPAR-gamma coactivations and splice variants thereof
JP2003210183A (ja) ヒトＩκＢ−β
US6359116B1 (en) Compounds
US7118885B2 (en) Nucleic acid encoding vitamin D receptor related polypeptide
KR20040039320A (ko) 인간호르몬의 비키메라 유사체를 제조하는 방법
JPH11151094A (ja) 免疫グロブリン遺伝子スーパーファミリーのメンバーｐｉｇｒｌ−１
MXPA00003667A (en) Novel vitamin d receptor related polypeptides, nucleic acid sequence encoding the same and uses thereof
JP2002517259A (ja) Ａｃｒｐ３０（３０ｋｄ脂肪細胞補体関連タンパク質）の相同体ａｃｒｐ３０ｒ２
CA2248987A1 (en) Novel compounds
JP2002513548A (ja) サイトカインファミリーメンバー２−１９
CA2244211A1 (en) Novel compounds
JP2002281987A (ja) Ｓｂｐｅｒｒ４ポリペプチドおよびポリヌクレオチド
JP4081130B2 (ja) 糖タンパク質ホルモンスーパーアゴニスト
KR100497685B1 (ko) 당단백질 호르몬 초활성 효능약
JP2002330793A (ja) 重炭酸ナトリウム共輸送体ファミリーのメンバーであるｈｎｂｃ１ａ
US20040087525A1 (en) Polypeptide-human rna binding protein 19 and the polynucleotide encoding it
JP2002515452A (ja) ＡＣＲＰ３０（３０ｋＤの脂肪細胞補体関連タンパク質）の相同体であるＡＣＲＰ３０Ｒ１
JP2002511488A (ja) 新規化合物
JP2002504377A (ja) ヒトシステインプロテアーゼｃｐｒｏｔ０３

Legal Events

Date Code Title Description
TC Change of applicant's name (sec. 104)

Owner name: PHARMACIA AB

Free format text: FORMER NAME: PHARMACIA AND UPJOHN AB

FGA Letters patent sealed or granted (standard patent)
PC Assignment registered

Owner name: BIOVITRUM AB

Free format text: FORMER OWNER WAS: PHARMACIA AB